NeuroVasc Technologies, Inc.

Medical device company · Laguna Hills, California, United States

NeuroVasc Technologies, Inc. is a medical device company headquartered in Laguna Hills, California, United States. Its earliest recorded incorporation is in 2015. The US FDA lists 1 medical device site registered to the company, with devices in cardiovascular and neurology. It has reported private securities offerings to the US SEC, most recently $500,000 sold in a notice filed in 2017.

Profile compiled from public records. Is this your company? Request a correction or update

NeuroVasc Technologies at a glance

Typemedical device company
HeadquartersLaguna Hills, California, United States
Earliest incorporation on record2015
FDA-registered sites1
SEC CIK1658372

What does NeuroVasc Technologies do?

Medical specialties of its FDA-listed devices

CardiovascularNeurology

Device types listed with the FDA

Catheter, thrombus retrieverCatheter, percutaneousDevice, neurovascular embolizationNeurovascular mechanical thrombectomy device for acute ischemic stroke treatment

Private fundraising reported to the SEC

3 Form D notices; the most recent reported $500,000 sold (2017).

Where is NeuroVasc Technologies located?

Headquarters: Laguna Hills, California, United States

  • Irvine, CaliforniaNeuroVasc Technologies, Inc. · FDA device site

Frequently asked questions about NeuroVasc Technologies

Where is NeuroVasc Technologies headquartered?

NeuroVasc Technologies, Inc. is headquartered in Laguna Hills, California, United States.

What does NeuroVasc Technologies do?

NeuroVasc Technologies, Inc. is a medical device company. Its FDA-listed medical devices fall under cardiovascular and neurology.

When was NeuroVasc Technologies founded?

The earliest incorporation on record for NeuroVasc Technologies, Inc. is in 2015, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences